Author:
Ludeman Susan M.,Gamcsik Michael P.
Reference90 articles.
1. Colvin OM. An overview of cyclophosphamide development and clinical applications. Curr Pharm Design, 5:555–560, 1999.
2. Vanhoefer U, Schleucher N, Klaassen Uet al.Ifosfamide-based drug combinations: Preclinical evaluation of drug interactions and translation into the clinic. Semin Oncol, 27, Suppl 1:8–13, 2000.
3. Kutz ME, Mulkerin DL, Wiedemann GJet al.In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustard. Cancer Chemother Pharmacol, 40:167–171, 1997.
4. Ludeman SM. The chemistry of the metabolites of cyclophosphamide. Curr Pharm Design, 5:627–643, 1999.
5. Boal JH, Williamson M, Boyd VLet al. 31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: Comparisons with phosphoramide mustard. J Med Chem, 32:1768–1773, 1989.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献